MYDA Advisors’s Nexalin Technology NXL Stock Holding History

MYDA Advisors’s Portfolio NXL Stock Details NXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-150,000	Closed	-$138K	–	187
2025 Q3	$138K	Sell	150,000 -650,000	-81%	-$614K	0.03%	150
2025 Q2	$790K	Buy	+800,000	New	+$1.12M	0.14%	102

Other funds holding NXL

PEAK6 Chicago, Illinois $42.6B AUM 66.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

MYDA Advisors's NXL Position: Q4 2025 in Review

MYDA Advisors sold out of Nexalin Technology (NXL) in Q4 2025, closing a stake of 150,000 shares — an estimated $138K sold.

MYDA Advisors first reported a position in NXL in Q2 2025 and held it in 2 quarters. The position peaked at $790K in Q2 2025. 19 funds tracked by Wall St. Rank hold NXL as of Q4 2025.

MYDA Advisors reported no remaining Nexalin Technology position as of Q4 2025 after selling out during the quarter.
MYDA Advisors sold 150,000 Nexalin Technology shares in Q4 2025, an estimated $138K.
MYDA Advisors first reported a position in Nexalin Technology in Q2 2025 and held it in 2 quarters.
MYDA Advisors's Nexalin Technology position peaked at $790K in Q2 2025.
19 funds tracked by Wall St. Rank held Nexalin Technology as of Q4 2025.

Based on MYDA Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.